본문 바로가기
자유게시판

Ther, our information uncovered HLH adult clients had a variable medic…

페이지 정보

작성자 Allie 작성일23-12-18 17:36 조회10회 댓글0건

본문

Ther, our data exposed HLH grownup patients experienced a variable scientific spectrum also as underlying health conditions. Individuals with lively EBV infection and lymphoma had poor survival. Sufferers with Fbg PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/3081428 and powerful treatment method like high-dosage chemotherapy combined with HSCT may very well be vital to those people.Competing interests The authors declare that they have no competing interests.Authors' contributions FL created, analyzed the data, and wrote the paper. FJ, JR, PL, YZ, GY contributed to clinical details collection. YY, RZ and MW contributed to statistical evaluation and reviewed the final results. YY and CD contributed for the revision on the manuscript, MW, RZ, YY and FL contributed into the 5-Fluoro-3-nitropyridin-2(1H)-one acceptance from the final manuscript. All authors study and accredited the ultimate manuscript.Acknowledgments The authors thank every one of the health professionals and nurses in the department of Hematology, Rheumatology, Infectious Division, Gastroenterology from the 1st Affiliated Hospital of Nanchang University. Writer specifics 1 Department of Hematology, The very first Affiliated Healthcare facility of Nanchang University, NanChang, China. 2Department of Urology, Tulane University Overall health Science Centre, New Orleans, LA, United states. 3Tumor Centre, The main Clinic of Jilin College, Changchun, China. 4Department of Pathology, College of Iowa Carver Higher education of medicine, Iowa City, Usa. 5State Critical Laboratory of Organic Medicines, College of Lifetime Science and Technologies, China Pharmaceutical College, Nanjing, China.References 1. Chandrakasan S, Filipovich AH. Hemophagocytic lymphohistiocytosis: improvements in pathophysiology, diagnosis, and treatment. J Pediatr. 2013;163:1253?. two. Larroche C. Hemophagocytic lymphohistiocytosis in older people: analysis and treatment. Joint Bone Spine. 2012;79:356?1. 3. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic pointers for hemophagocytic lymphohistiocytosis. Pediatr Blood Most cancers. 2007;forty eight:124?1. four. Canna SW, Behrens EM. Not all hemophagocytes are made similarly: appreciating the heterogeneity of the hemophagocytic syndromes. Curr Opin Rheumatol. 2012;24:113?. five. Fukaya S, Yasuda S, Hashimoto T, Oku K, Kataoka H, Horita T, et al. Medical attributes of haemophagocytic syndrome in clients with systemic autoimmune diseases: assessment of 30 circumstances. Rheumatology (Oxford). 2008;forty seven:1686?1. 6. Kuzmanova SI. The macrophage activation syndrome: a new entity, a most likely fatal complication of rheumatic issues. Folia Med. 2005;forty seven:21?. seven. Janka GE, Lehmberg K. Hemophagocytic syndromes n update. Blood Rev. 2014;28:135?two. 8. Sakamoto Y, Mariya2-(4-Carbamoylpiperidin-1-yl)acetic acid hydrochloride2-(4-Carbamoylpiperidin-1-yl)acetic acid hydrochloride title=View Abstract(s)">PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/8627573 virus infection. Tohoku J Exp Med. 2012;227:307?1. 9. Kaneko T, Wada H. Diagnostic conditions and laboratory checks for disseminated intravascular coagulation. J Clin Exp Hematop. 2011;51:sixty seven?6. ten. Henter J-I, Samuelsson-Horne A, Aric?M, Egeler RM, Elinder G, Filipovich AH, et al. Cure of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367?three. eleven. Strout MP, Seropian S, Berliner N. Alemtuzumab for a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis. Nat Rev Clin Oncol. 2010;7:415?0. 12. Trottestam H, Horne A, Arico M, Egeler RM, Filipovich AH, Gadner H, et al. Chemoimmunotherapy for hemophago.

댓글목록

등록된 댓글이 없습니다.

  • 주식회사 제이엘패션(JFL)
  • TEL 02 575 6330 (Mon-Fri 10am-4pm), E-MAIL jennieslee@jlfglobal.com
  • ADDRESS 06295 서울특별시 강남구 언주로 118, 417호(도곡동,우성캐릭터199)
  • BUSINESS LICENSE 234-88-00921 (대표:이상미), ONLINE LICENCE 2017-서울강남-03304
  • PRIVACY POLICY